Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zi-Yao Hu"'
Autor:
Dong-Xi Wang, Yan-Lin Ye, Cheng-Jian Lin, Jia-Hao Chen, Kai Ma, Jia-Xing Han, Hui-Ming Jia, Lei Yang, Li-Sheng Yang, Zi-Yao Hu, Ying Chen, Wei-Liang Pu, Gen Li, Zhi-Wei Tan, Hong-Yu Zhu, Tian-Peng Luo, Shan-Hao Zhong, Da-Hu Huang, Jian-Ling Lou, Xiao-Fei Yang, Qi-Te Li, Jin-Yan Xu, Zai-Hong Yang, Kang Wei
Publikováno v:
Chinese Physics C. 47:014001
A transfer reaction and cluster-decay experiment, C( O, Mg α+ Ne)α, was performed at a beam energy of 96 MeV. Both recoil and decay α particles were detected in coincidence, allowing us to deduce the energy-momentum of a Ne fragment. A number of r
Autor:
Zi-Jing Li, William Pat Fong, Dong-Sheng Zhang, Hui-Yan Luo, Dong-Liang Chen, Yan-Yu Cai, Zhi-Gang Chen, Jian-Li Duan, Zi-Yao Huang, Yu-Ting Lu, Xiao-Xia Huang, Yu-Hong Li, De-Shen Wang
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-6 (2024)
Abstract Anaplastic lymphoma kinase (ALK) fusion-positive colorectal cancer (CRC) is a rare and chemotherapy-refractory subtype that lacks established and effective treatment strategies. Additionally, the efficacy and safety of ALK inhibitors (ALKi)
Externí odkaz:
https://doaj.org/article/bbdc714779f84f3980277043828d8a35
Autor:
Zi-Yao Huang, Lei Wen, Liu-Fang Ye, Yu-Ting Lu, William Pat Fong, Ren-Jing Zhang, Si-Xian Wu, Zhi-Gang Chen, Yan-Yu Cai, Rui-Hua Xu, Yu-Hong Li, Zi-Ming Du, De-Shen Wang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Transmembrane E3 ubiquitin ligase ( RNF43 ) mutations are present in approximately 6–18% of colorectal cancers (CRC) and could enhance Wnt/β-catenin signaling, which is emerging as a promising therapeutic target. This study aims to inv
Externí odkaz:
https://doaj.org/article/d267fbf1f23c40f6a8146f578616f919